Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115288085 | 11528808 | 5 | F | 20150807 | 20160726 | 20150921 | 20160801 | EXP | US-PFIZER INC-2015308592 | PFIZER | 46.00 | YR | F | Y | 69.00000 | KG | 20160801 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115288085 | 11528808 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, 1X/DAY | N | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | QD | |||||
| 115288085 | 11528808 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | N | 20699 | PROLONGED-RELEASE CAPSULE | ||||||||||
| 115288085 | 11528808 | 3 | SS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 37.5 MG, 2X/DAY | N | 20699 | 37.5 | MG | TABLET | BID | |||||
| 115288085 | 11528808 | 4 | SS | ATENOLOL. | ATENOLOL | 1 | 12.5 MG, 1X/DAY | N | 73676 | 12.5 | MG | TABLET | QD | ||||||
| 115288085 | 11528808 | 5 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | 50 MG, 1X/DAY (QPM) | N | 73676 | 50 | MG | TABLET | QD | |||||
| 115288085 | 11528808 | 6 | C | LISINOPRIL HCTZ | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | Oral | LISINOPRIL 20 MG/HCTZ 12.5 MG, 1X/DAY (Q AM) | 0 | TABLET | QD | ||||||||
| 115288085 | 11528808 | 7 | C | LO LOESTRIN FE | ETHINYL ESTRADIOLNORETHINDRONE ACETATE | 1 | 1 DF, 1X/DAY (ETHINYLESTRADIOL: 1 MG, FERROUS FUMARATE: 10 MCG, NORETHISTERONE ACETATE: 10 MCG) | 0 | 1 | DF | TABLET | QD | |||||||
| 115288085 | 11528808 | 8 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | 20 MG, 2X/DAY | 0 | 20 | MG | TABLET | BID | |||||||
| 115288085 | 11528808 | 9 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | 20 MG, 2X/DAY | 0 | 20 | MG | TABLET | BID | |||||||
| 115288085 | 11528808 | 10 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Oral | 10 MG, AS NEEDED (MAYBE TWICE A WEEK) | 0 | 10 | MG | ||||||||
| 115288085 | 11528808 | 11 | C | VALIUM | DIAZEPAM | 1 | 5 MG, AS NEEDED (TWICE DAILY) | 0 | 5 | MG | |||||||||
| 115288085 | 11528808 | 12 | C | VITAMIN C | ASCORBIC ACID | 1 | 1500 MG, 1X/DAY | 0 | 1500 | MG | TABLET | QD | |||||||
| 115288085 | 11528808 | 13 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | 400 IU, 1X/DAY | 0 | 400 | IU | CAPSULE | QD | |||||||
| 115288085 | 11528808 | 14 | C | OSTEO BI-FLEX | CHONDROITIN SULFATE AGLUCOSAMINE | 1 | STRENGTH 250-200 MG TABLET 2 TABLETS AFTER MEALS THREE TIMES A DAY | 0 | 2 | DF | TABLET | TID | |||||||
| 115288085 | 11528808 | 15 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | UNK | 0 | |||||||||||
| 115288085 | 11528808 | 16 | C | CALCIUM | CALCIUM | 1 | 500 MG, 1X/DAY (WITH MEALS) | 0 | 500 | MG | TABLET | QD | |||||||
| 115288085 | 11528808 | 17 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | 50 UG, 1X/DAY (2 SPRAYS IN EACH NOSTRIL ONCE A DAY) | 0 | 50 | UG | NASAL SPRAY | QD | ||||||
| 115288085 | 11528808 | 18 | C | CLARITIN | LORATADINE | 1 | Oral | 10 MG, AS NEEDED (1 TABLET ONCE A DAY) | 0 | 10 | MG | TABLET | |||||||
| 115288085 | 11528808 | 19 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 115288085 | 11528808 | 20 | C | DOXYCYCLINE HYCLATE. | DOXYCYCLINE HYCLATE | 1 | 200 MG, 1X/DAY | 0 | 200 | MG | TABLET | QD | |||||||
| 115288085 | 11528808 | 21 | C | ESCITALOPRAM OXALATE. | ESCITALOPRAM OXALATE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115288085 | 11528808 | 1 | Depression |
| 115288085 | 11528808 | 2 | Fibromyalgia |
| 115288085 | 11528808 | 3 | Depression |
| 115288085 | 11528808 | 4 | Tachycardia |
| 115288085 | 11528808 | 5 | Hypertension |
| 115288085 | 11528808 | 6 | Hypertension |
| 115288085 | 11528808 | 7 | Contraception |
| 115288085 | 11528808 | 8 | Attention deficit/hyperactivity disorder |
| 115288085 | 11528808 | 10 | Insomnia |
| 115288085 | 11528808 | 11 | Fibromyalgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115288085 | 11528808 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115288085 | 11528808 | Agitation | |
| 115288085 | 11528808 | Anxiety | |
| 115288085 | 11528808 | Blood pressure increased | |
| 115288085 | 11528808 | Dizziness | |
| 115288085 | 11528808 | Feeling abnormal | |
| 115288085 | 11528808 | Heart rate decreased | |
| 115288085 | 11528808 | Heart rate increased | |
| 115288085 | 11528808 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115288085 | 11528808 | 1 | 201508 | 2015 | 0 | |
| 115288085 | 11528808 | 3 | 201508 | 2015 | 0 | |
| 115288085 | 11528808 | 4 | 201508 | 0 | ||
| 115288085 | 11528808 | 8 | 200106 | 201510 | 0 | |
| 115288085 | 11528808 | 9 | 20160212 | 0 | ||
| 115288085 | 11528808 | 10 | 2001 | 0 | ||
| 115288085 | 11528808 | 11 | 201502 | 0 |